2023 Community Individual Management 
The Medical Futurist
JUNE 19, 2025
Determining patients’ prognosis Due to individual variations in genetics and lifestyle choices, each person ages at a different rate. However, this visual assessment can be impaired by individual biases, thereby impacting objective care decisions. FaceHeart also received FDA approval for the heart rate component in 2023.
My Green Doctor
APRIL 4, 2025
Todd Sack concludes that, “ the medical office waiting room appears to be an accepted, time-efficient, and effective site to communicate knowledge on climate change and health. ” According to the 2023 report of the Lancet Countdown, mortality caused by extreme heat events increased by 53.7% Contact us today! of total U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Common Sense Family Doctor
DECEMBER 27, 2024
In 2023, a decade after the Affordable Care Act expanded Medicaid and began offering subsidized private insurance options in national and state-run marketplaces, the share of the population with health insurance reached 92.5% - the highest ever. Nevertheless, the U.S. is at the threshold of a once-in-a-lifetime opportunity.
The Clinical Problem Solvers
APRIL 3, 2023
[link] CPSolvers: Anti-Racism in Medicine Series Episode 20 – Medical Racism and Indigenous Peoples Show Notes by Sudarshan (“Sud”) Krishnamurthy April 4, 2023 Summary: This episode highlights the checkered past of medicine and the advancements in the field that have occurred at the expense of the humanity of Indigenous peoples.
FDA Law Blog
JULY 17, 2024
Peter Marks at James Valentine ’s FDA Rare Disease Town Hall session at the DIA Annual Meeting last month (see Pink Sheet coverage here ), this Hub is intended to serve as the Center of Excellence that we in the rare disease community have been calling for its establishment over the last several years.
The Clinical Problem Solvers
DECEMBER 16, 2020
Moreover, center patients not only in discussions about individual decision-making but in constructing and drawing meaning from the research. However, the diagnostic approach used to determine changes in clinical management of renal disease (i.e. J Epidemiol Community Health. J Gen Intern Med. 2020;35(9):2760-2762.
FDA Law Blog
NOVEMBER 14, 2022
The guidance explains that a facility counts as a single facility subject to a single facility fee if it is under one management and in one geographic location and address, and is engaged in manufacturing or processing the finished dosage form of an OTC monograph drug product. The facility fee applies to a single manufacturing facility.
Expert insights. Personalized for you.
96 
Let's personalize your content